Ramon Gutiérrez-Sánchez

Mr. Ramon Gutiérrez-Sánchez

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

5 April 2011 in Journal of Natural Products
Verified
Journal Article
Closed access
CMClotilde Marín
Clotilde Marín
Inmaculada Ramírez-MacíasInmaculada Ramírez-Macías
Inmaculada Ramírez-Macías
ALAngeles López-Céspedes
Angeles López-Céspedes
FOFrancisco Olmo
Francisco Olmo
NVNoelia Villegas
Noelia Villegas
MSManuel Sánchez-Moreno
Manuel Sánchez-Moreno

1 October 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ANA B. CABALLEROANA B. CABALLERO
ANA B. CABALLERO
Antonio Rodriguez-DieguezAntonio Rodriguez-Dieguez
Antonio Rodriguez-Dieguez
MQMiguel Quirós
Miguel Quirós
JSJuan M. Salas
Juan M. Salas
ÓHÓscar Huertas
Óscar Huertas
MSManuel Sánchez-Moreno
Manuel Sánchez-Moreno

2 June 2009 in Journal of Natural Products
Verified
Journal Article
Closed access
CMClotilde Marín
Clotilde Marín
SBSamira Boutaleb-Charki
Samira Boutaleb-Charki
JDJesús G. Díaz
Jesús G. Díaz
OHOscar Huertas
Oscar Huertas
MRMaría J. Rosales
María J. Rosales
MSManuel Sánchez-Moreno
Manuel Sánchez-Moreno

1 January 2009 in Drug Metabolism Letters
Verified
Journal Article
Closed access
PDF file
SBSamira Boutaleb-Charki
Samira Boutaleb-Charki
CMClotilde Marín
Clotilde Marín
CMCarmen R. Maldonado
Carmen R. Maldonado
MRMaria J. Rosales
Maria J. Rosales
JUJesus Urbano
Jesus Urbano
MSManuel Sanchez-Moreno
Manuel Sanchez-Moreno
Anti-proliferative effects are described for newly synthesised copper (II) complexes of two triazolo-pyrimidine derivatives (1,2,4-triazolo-[1,5-a]pyrimidine, tp, and 5,7-dimethyl 1,2,4-triazolo-[1,5-a]pyrimidine, dmtp) against to Trypanosoma cruzi and Leishmania (Viannia) peruviana. Of the compounds assayed, those that presented the ligand tp and auxiliary ligand 1,10-phenanthroline (C24b, C49) were most highly active against to T. cruzi with IC50 within the range of the reference drug benznidazole. These compounds, together with C35 were the most effective against L. (V.) peruviana with an IC50 greater than that presented by reference drugs (Pentostam and Glucantim). These compounds were not toxic to the host cell. IC25 diminished the infection capacity and severely reduced the multiplication of intracellular forms of T. cruzi, and L. (V.) peruviana. In the case of T. Cruzi, the transformation to trypomastigote was seriously depressed. Copper (II) complexes C24b, C49 and C35, acted on the energy metabolism of the parasites at the level of the NAD/NADH balance and at the level of the organelle membranes, causing degradation and cell death.

1 July 2012 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
Inmaculada Ramírez-MacíasInmaculada Ramírez-Macías
Inmaculada Ramírez-Macías
CMCarmen R. Maldonado
Carmen R. Maldonado
CMClotilde Marín
Clotilde Marín
FOFrancisco Olmo
Francisco Olmo
RGRamon Gutiérrez-Sánchez
Ramon Gutiérrez-Sánchez
MSManuel Sánchez-Moreno
Manuel Sánchez-Moreno